Blocking the ability of huntingtin to bind membranes: a therapeutic strategy for Huntingtons disease
C. Siriwardhana, A. Adegbuyiro, F. Sedighi, A. R. Stonebraker, S. Leonard, M. Beasley, A. Skeens, B. Mertz, W. J. Geldenhuys, J. Legleiter
This study evaluates blocking huntingtin membrane binding as a therapeutic strategy for HD, identifying two compounds that alleviate HD phenotypes in C. elegans.
bioRxiv · Jul 17, 2024 · PreprintBiophysics